A carregar...
Systemic Therapy for Invasive Bladder Cancer: The Value Proposition
Neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy followed by definitive local treatment should be the treatment of choice for otherwise healthy and robust patients with T2b–T4 invasive bladder cancer.
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AlphaMed Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4912376/ https://ncbi.nlm.nih.gov/pubmed/27125752 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0074 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|